Claudia Neuber - Patented Drug Pricing and Coverage
-
Upload
pharmacare-2020 -
Category
Documents
-
view
247 -
download
0
Transcript of Claudia Neuber - Patented Drug Pricing and Coverage
![Page 1: Claudia Neuber - Patented Drug Pricing and Coverage](https://reader036.fdocuments.net/reader036/viewer/2022062307/5584f484d8b42a73618b5166/html5/thumbnails/1.jpg)
Challenges and InnovationIndustry view
Claudia Neuber
Pharma 2020
Vancouver
February 2013
STRICTLY CONFIDENTIAL – NOT TO BE DISTRIBUTED EXTERNALLY
![Page 2: Claudia Neuber - Patented Drug Pricing and Coverage](https://reader036.fdocuments.net/reader036/viewer/2022062307/5584f484d8b42a73618b5166/html5/thumbnails/2.jpg)
The views expressed in this document are those of the author.
They do not necessarily represent the views
of AstraZeneca Canada Inc or Rx&D and its members.
Disclaimer
![Page 3: Claudia Neuber - Patented Drug Pricing and Coverage](https://reader036.fdocuments.net/reader036/viewer/2022062307/5584f484d8b42a73618b5166/html5/thumbnails/3.jpg)
Pricing – it used to be simple....
• One price for all customers.
• No product listing agreements.
• Limited tenders.
• Stable environment.
• Limited price referencing.
![Page 4: Claudia Neuber - Patented Drug Pricing and Coverage](https://reader036.fdocuments.net/reader036/viewer/2022062307/5584f484d8b42a73618b5166/html5/thumbnails/4.jpg)
Payer
Parent company
Pharmaceutical Pricing in Canada
![Page 5: Claudia Neuber - Patented Drug Pricing and Coverage](https://reader036.fdocuments.net/reader036/viewer/2022062307/5584f484d8b42a73618b5166/html5/thumbnails/5.jpg)
A Complex Market
National
• Patented Medicines Prices Review Board
• Common Drug review, pCODR - all but Quebec
• PWGSC contracting for certain products
Canada represents about 2-3% of most global businesses
Provinces
• Product listings, PLA and contract
negotiations
• 40 private payers
• Differential pricing
• Pharmacist practices and regulations
• Public Health programs and
vaccinations programs
![Page 6: Claudia Neuber - Patented Drug Pricing and Coverage](https://reader036.fdocuments.net/reader036/viewer/2022062307/5584f484d8b42a73618b5166/html5/thumbnails/6.jpg)
International Price Referencing
Ref. http://apps.who.int/medicinedocs/en/d/Jh2951e/2.3.5.html WHO workshop on differential pricing in 2001
• Significant financial implications for industry if you get it wrong
• Complex and constantly changing
• Requires active monitoring and management
![Page 7: Claudia Neuber - Patented Drug Pricing and Coverage](https://reader036.fdocuments.net/reader036/viewer/2022062307/5584f484d8b42a73618b5166/html5/thumbnails/7.jpg)
Launch Timing
Ref: Sarah Ray, Cutting Edge Information, February 1, 2013
![Page 8: Claudia Neuber - Patented Drug Pricing and Coverage](https://reader036.fdocuments.net/reader036/viewer/2022062307/5584f484d8b42a73618b5166/html5/thumbnails/8.jpg)
Opportunities and challenges
Trust and dialogue
Recognition of differences
Complex situations
A rapidly changing environment
Managing expectations